PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Lopez, J.P.* ; Luecken, M. ; Brivio, E.* ; Karamihalev, S.* ; Kos, A.* ; De Donno, C. ; Benjamin, A.* ; Yang, H.* ; Dick, A.L.W.* ; Stoffel, R.* ; Flachskamm, C.* ; Ressle, A.* ; Roeh, S.* ; Huettl, R.E.* ; Parl, A.* ; Eggert, C.* ; Novak, B.* ; Yan, Y.* ; Yeoh, K.* ; Holzapfel, M.* ; Hauger, B.* ; Harbich, D.* ; Schmid, B.* ; Di Giaimo, R.* ; Turck, C.W.* ; Schmidt, M.V.* ; Deussing, J.M.* ; Eder, M.* ; Dine, J.* ; Theis, F.J. ; Chen, A.*

Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2.

Neuron 110, 2283-2298.e9 (2022)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
A single sub-anesthetic dose of ketamine produces a rapid and sustained antidepressant response, yet the molecular mechanisms responsible for this remain unclear. Here, we identified cell-type-specific transcriptional signatures associated with a sustained ketamine response in mice. Most interestingly, we identified the Kcnq2 gene as an important downstream regulator of ketamine action in glutamatergic neurons of the ventral hippocampus. We validated these findings through a series of complementary molecular, electrophysiological, cellular, pharmacological, behavioral, and functional experiments. We demonstrated that adjunctive treatment with retigabine, a KCNQ activator, augments ketamine's antidepressant-like effects in mice. Intriguingly, these effects are ketamine specific, as they do not modulate a response to classical antidepressants, such as escitalopram. These findings significantly advance our understanding of the mechanisms underlying the sustained antidepressant effects of ketamine, with important clinical implications.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
18.688
0.000
3
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Kcnq ; Kcnq2 ; Cell-type Specific ; Ezogabine ; Glutamatergic Neurons ; Ketamine ; Retigabine ; Single-cell Rna Sequencing ; Sustained Antidepressant Response ; Ventral Hippocampus
Language english
Publication Year 2022
HGF-reported in Year 2022
ISSN (print) / ISBN 0896-6273
e-ISSN 1097-4199
Journal Neuron
Quellenangaben Volume: 110, Issue: 14, Pages: 2283-2298.e9 Article Number: , Supplement: ,
Publisher Cell Press
Publishing Place Cambridge, Mass.
Reviewing status Peer reviewed
Institute(s) Institute of Computational Biology (ICB)
POF-Topic(s) 30205 - Bioengineering and Digital Health
Research field(s) Enabling and Novel Technologies
PSP Element(s) G-503800-001
DOI 10.1016/j.neuron.2022.05.001
WOS ID WOS:000843086800010
Scopus ID 85134762071
PubMed ID 35649415
Erfassungsdatum 2022-07-11
[➜Report correction]